Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) A61K 31/437 (2006.01)

Patent

CA 2525245

The present invention provides compounds of formula (I), the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2 and R3 are as defined herein; pharmaceutical formulations thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as bipolar disorder, diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.

La présente invention concerne des composés de formule (I), leurs stéréoisomères et promédicaments, ainsi que les sels pharmaceutiquement acceptables des composés, stéréoisomères et promédicaments. Dans cette formule, R?1¿, R?2¿ et R?3¿ sont tels que définis dans la description. L'invention concerne également des formulations pharmaceutiques de ces composés et leur utilisation pour traiter, entre autres, des pathologies, des maladies et des symptômes, par exemple le trouble bipolaire, le diabète, la démence, la maladie d'Alzheimer, les accidents cérébraux vasculaires, la schizophrénie, la dépression, la chute des cheveux et le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1769266

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.